Consensus
The community sees this as very unlikely for AstraZeneca at 25%, based on 6 forecasts. Forecasters are in moderate agreement.
Resolves YES if AstraZeneca is down more than 16% 90 days out versus its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole azn discussion →